Nature Medicine (June 22, 2020) Tau molecular diversity contributes to clinical heterogeneity in Alzheimer’s disease.

Dr. Seth Gale of Brigham & Women’s Center for Alzheimer Research and Treatment discusses the status of research studies during COVID-19. The interview also features clinical trial research participant Alice Bailey.

https://www.boston25news.com/news/health/critical-medical-research-put-hold-amid-pandemic/XQKJYGGXOVEK7IHU222B2OP2RM/?_website=cmg-tv-10020